Quantcast
Last updated on April 19, 2014 at 21:20 EDT

Latest Vaccination Stories

2013-11-12 09:13:31

Also reports on trial of new brain cancer vaccine; brain stimulation causes 'foreign accent syndrome' Hospitals vary in management of children with traumatic brain injury—particularly in monitoring and preventing the harmful effects of increased intracranial pressure (ICP), according to a study in the November issue of Neurosurgery, official journal of the Congress of Neurological Surgeons. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health....

2013-11-12 08:34:31

PRINCETON, N.J., Nov. 12, 2013 /PRNewswire/ -- Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics, announced today its financial results for the quarter and nine months ended September 30, 2013. Soligenix's revenues for the quarter and nine months ended were $0.3...

2013-11-12 08:33:56

Inovio marks quarter with significant partnership with Roche BLUE BELL, Pa., Nov. 12, 2013 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today reported financial results for the quarter ended September 30, 2013. Total revenue was $9.5 million and $11.7 million for the three and nine months ended September 30, 2013, compared to $855,000 and $3.0 million for the same periods in 2012. Total operating expenses were $8.7 million and $23.3 million for the three and nine...

2013-11-08 12:23:21

GAITHERSBURG, Md., Nov. 8, 2013 /PRNewswire-iReach/ -- Panacea Pharmaceuticals, Inc. presents three papers regarding its Nanoparticle-Based Therapeutic Cancer Vaccine at the Society for Immunotherapy of Cancer Annual Meeting at National Harbor, MD held November 8-10, 2013. The three papers are titled: Design, Development and Production of Nano-Particle-Based Anticancer Vaccine Targeting Human Aspartyl (Asparaginyl) b-Hydroxylase (HAAH) Immunogenicity of a Lambda Phage-Based...

2013-11-08 08:25:30

NYU's Dr. Marc Siegel Discusses DCVax And Its Life-Extending Potential As A Cancer Therapy BETHESDA, Md., Nov. 8, 2013 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO)(NW Bio), a biotechnology company developing non-toxic DCVax(®) personalized immune therapies for solid tumor cancers, announced today that their vaccine was featured yesterday in news coverage on both Fox News and Fox Business News. (Logo: http://photos.prnewswire.com/prnh/20110329/SF73084LOGO) The...

2013-11-06 23:32:03

A study published in the October 28, 2013 Pediatrics Journal entitled, “Influenza-Associated Pediatric Deaths in the United States, 2004–2012” found 11% of the deaths were made up of infants under 6 months considered too young for flu shots. Photo-oxidation protection provided by UV-Aid kills bacteria and viruses helping to prevent colds, flu, and infections. Fort Myers, FL (PRWEB) November 05, 2013 A nearly decade long study documenting flu related fatalities in adolescents aged 18...

2013-11-05 23:24:26

The results show that Colby’s JVRS-100 adjuvant, when used in combination with an influenza virus vaccine, generates enhanced immunity and superior protection of elderly monkeys when challenged with live human flu virus (relative to the vaccine alone). San Jose, CA (PRWEB) November 05, 2013 Colby Pharmaceutical Company (CPC) announces ground-breaking results demonstrating that two inoculations of Colby’s JVRS-100 adjuvant, in combination with Fluzone influenza vaccine, enhance the...

2013-11-05 23:18:43

A study published in the October 28, 2013 Pediatrics Journal entitled, “Influenza-Associated Pediatric Deaths in the United States, 2004–2012” found 11% of the deaths were made up of infants under 6 months considered too young for flu shots. Photo-oxidation protection provided by UV-Aid kills bacteria and viruses helping to prevent colds, flu, and infections. Fort Myers, FL (PRWEB) November 05, 2013 A nearly decade long study documenting flu related fatalities in adolescents aged 18...

2013-11-05 12:28:08

Experts from Industry and Academia Discussed the Medical Potential of Messenger RNA (mRNA) TUEBINGEN, Germany, Nov. 5, 2013 /PRNewswire/ -- The 1st International mRNA Health Conference in Tuebingen on Oct. 23 and 24 brought together for the first time more than 150 attendees from leading international pharmaceutical and biotechnology companies and academic institutions. The attendees discussed in the two-day event the tremendous medical potential of mRNA for many therapeutic...

2013-11-05 08:36:07

SAN DIEGO, Nov. 5, 2013 /PRNewswire/ -- Pfenex Inc. today announced that it has awarded Paragon Bioservices a contract for the current Good Manufacturing Practice (cGMP) manufacturing of its rPA based anthrax vaccine. Paragon Bioservices will implement the cGMP-ready Pfenex Expression Technology(TM)-based production process that has been developed at Pfenex, through its vaccines division. Funding will be provided by the Department of Health and Human Services (HHS), through the...


Latest Vaccination Reference Libraries

0_ac8af9115d7f37daaaa2af4dba273fb1
2011-01-11 14:17:29

The Cowpox virus causes a skin disease known as cowpox. It is related to the vaccinia virus and gained its name because it spread by dairymaids touching the udders of infected cows. It manifests as red blisters. It is similar to smallpox although much milder and was actually the basis of the first smallpox vaccine. A person who recovers from cowpox is immune to smallpox. In 1980 the World Health Organization announced that smallpox was the first disease to be eradicated world wide by a...

More Articles (1 articles) »